収縮期高血圧(Systolic Hypertension):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Systolic Hypertension Global Clinical Trials Review, H2, 2014
◆発行会社/調査会社:GlobalData
◆商品コード:GDHC2354CTIDB
◆発行日:2014年9月30日
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:98
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[収縮期高血圧(Systolic Hypertension):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら
本調査レポートでは、世界における収縮期高血圧(Systolic Hypertension)の臨床研究の最新動向について調査・分析し、アジア太平洋、欧州、北米、中南米、中東・アフリカなど各地域における治験状況、段階別の治験件数、進捗状況別の治験件数、スポンサーの種類別治験件数、有望な薬剤、治験関連ニュース、治験のプロファイル情報等をお届けします。

・イントロダクション
  - 収縮期高血圧(Systolic Hypertension)
  - 当レポートの概要

・各地域別治験状況
  - 各国の治験件数及び平均被験者数
  - アジア太平洋の主要国における治験件数
  - 欧州の主要国における治験件数
  - 北米の主要国における治験件数
  - 中東・アフリカの主要国における治験件数
  - 中南米の主要国における治験件数
  - G7諸国での治験件数
  - G7諸国での治験件数:進捗状況別
  - E7諸国(新興7カ国)での治験件数
  - E7諸国での治験件数:進捗状況別

・段階別の治験件数
  - 進行中の治験:段階別

・進捗状況別の治験件数

・治験目標の達成状況

・未完了の治験件数

・一定期間に採用された被験者

・スポンサーの種類別治験件数

・有望なスポンサー

・有望な薬剤

・収縮期高血圧(Systolic Hypertension)治験関連ニュース

・治験のプロファイル
  - 主要企業の治験概要
  - 主要研究機関・病院の治験概要
  - 5つの代表的な治験のプロファイル
*** レポート概要(サマリー)***

Systolic Hypertension Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Systolic Hypertension Global Clinical Trials Review, H2, 2014″ provides data on the Systolic Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Systolic Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Systolic Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Systolic Hypertension 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Systolic Hypertension to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Systolic Hypertension to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Systolic Hypertension 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Systolic Hypertension Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Systolic Hypertension 32
Sep 09, 2014: Serodus Announces Positive Phase IIa Clinical Study Results On SER100 In Patients with Systolic Hypertension 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Merck & Co., Inc. 34
Clinical Trial Overview of Merck & Co., Inc. 34
Synvista Therapeutics, Inc. 35
Clinical Trial Overview of Synvista Therapeutics, Inc. 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Gilead Sciences, Inc. 37
Clinical Trial Overview of Gilead Sciences, Inc. 37
C. H. Boehringer Sohn AG & Co. KG 38
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 38
Actavis plc 39
Clinical Trial Overview of Actavis plc 39
Serodus ASA 40
Clinical Trial Overview of Serodus ASA 40
Daiichi Sankyo Company, Limited 41
Clinical Trial Overview of Daiichi Sankyo Company, Limited 41
Clinical Trial Overview of Top Institutes / Government 42
National Heart, Lung, and Blood Institute 42
Clinical Trial Overview of National Heart, Lung, and Blood Institute 42
Wayne State University 43
Clinical Trial Overview of Wayne State University 43
Katholieke Universiteit Leuven 44
Clinical Trial Overview of Katholieke Universiteit Leuven 44
St. John’s Health System 45
Clinical Trial Overview of St. John’s Health System 45
University of Chicago 46
Clinical Trial Overview of University of Chicago 46
University of Connecticut Health Center 47
Clinical Trial Overview of University of Connecticut Health Center 47
University of Dundee 48
Clinical Trial Overview of University of Dundee 48
CAMC Health System 49
Clinical Trial Overview of CAMC Health System 49
Monash University 50
Clinical Trial Overview of Monash University 50
University of Minnesota 51
Clinical Trial Overview of University of Minnesota 51
Five Key Clinical Profiles 52
Appendix 96
Abbreviations 96
Definitions 96
Research Methodology 97
Secondary Research 97
About GlobalData 98
Contact Us 98
Disclaimer 98
Source 98

List of Tables
Systolic Hypertension Therapeutics, Global, Clinical Trials by Region, 2014* 7
Systolic Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Systolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Systolic Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Systolic Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Systolic Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Systolic Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Systolic Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Systolic Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Systolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Systolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Systolic Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Systolic Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Systolic Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Systolic Hypertension Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Systolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Systolic Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Systolic Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Systolic Hypertension Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Systolic Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Systolic Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Systolic Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Systolic Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Systolic Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 33
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 34
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Synvista Therapeutics, Inc., 2014* 35
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 36
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 37
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 38
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 39
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Serodus ASA, 2014* 40
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 41
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 42
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Wayne State University, 2014* 43
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Katholieke Universiteit Leuven, 2014* 44
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by St. John's Health System, 2014* 45
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014* 46
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Connecticut Health Center, 2014* 47
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2014* 48
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by CAMC Health System, 2014* 49
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Monash University, 2014* 50
Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 51

List of Figures
Systolic Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Systolic Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Systolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Systolic Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Systolic Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Systolic Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Systolic Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Systolic Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Systolic Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Systolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Systolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Systolic Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Systolic Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Systolic Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Systolic Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Systolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Systolic Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Systolic Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Systolic Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Systolic Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Systolic Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Systolic Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Systolic Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 97

*** レポートのキーワード ***

収縮期高血圧(Systolic Hypertension)、治験(臨床試験)、製薬

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHC2354CTIDB )"収縮期高血圧(Systolic Hypertension):世界の治験レビュー(2014年下半期版)" (英文:Systolic Hypertension Global Clinical Trials Review, H2, 2014)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。